Specialty: Medical Oncology Consultant
Telephone: +35722100945
Other Telephones: +35799457262
Fax: +35722100947
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

---

CV

Medical School:
Semmelweis University Of Medicine
________________________________________

Training:
Specialty training in the UK.
Poole Hospital, Royal Marsden Hospital, The Royal Bournemouth Hospital
MSc in Medical Oncology, Newcastle

________________________________________
Residency:

Nicosia General Hospital, Cyprus
________________________________________

Fellowships:
Clinical Research Fellow in Medical Oncology
________________________________________

Certification:
Member of the European Society Of Medical Oncology (ESMO)
Member of the American Society Of Clinical Oncology (ASCO)
Member of the Oncology Multi-Disciplinary Teams
Member of Cyprus Medical Association
Member of Cyprus Oncology Society
Member of the Oncology Department at YGIA Polyclinic Private Hospital
________________________________________

Academic Interests:
Lung, Breast, Gastro-intestinal, Renal Cancers, Sarcomas and Melanomas.

________________________________________

Professional Highlights:
Involvement International Phase 2 and Phase 3 trials.
Development of Acute Oncology Service.
Development of End of Treatment Assessment-Oncology follow up and Assessment Guidelines.
Development of Oncology-Triage Guidelines.
Peer Review member of the European Medical Journal of Oncology.
Co - Developer of Electronic Prescribing System of Oncology
Co-author of the Medical Oncology Handbook for RBCH.
Development of Oncology e-learning modules.
Development of Patient Educational Neutropenic Sepsis DVD.
Training of Nurses & Doctors in Oncology, (Dorset Cancer Network, Royal Marsden Hospital).

________________________________________

Publications:
Dunlop, M. G., S. E. Dobbins, et al. (2012). "Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk." Nat Genet 44(7): 770-776.
G.Astras,Hickish.T ,L.Purandare Diagnosis and managemnet of Isolated Pituitary Metastasis from adenocarcinoma of uknown origin presenting as losss of libido. July 2012
G.Astras ,L.Purandare-Use of Avastin in cutaneous metastatic breast cancer July 2012
Geldart, T. and G. Astras (2011). "Isolated CNS relapse in human epidermal growth factor receptor 2-positive esophagogastric cancer: effective treatment with trastuzumab after failure of surgery and radiotherapy." J Clin Oncol 29(23): e664-665.
Hickish, T., G. Astras, et al. (2009). "Glucose intolerance during adjuvant chemotherapy for breast cancer." J Natl Cancer Inst 101(7): 537.
An epidemiological assessement of the lifestyle Factors which may be associated with the development of Barretts oesophagus-CARBO study- Dr David Kerr,Dr T.Hickish,Dr.G.Astras,Dr.J.Ainley Jan 2007

 

 

• < Prev
• Next >